In another study carried out by Ruiz et al. [27], the loss of AP-2α, very early in the progression of cancer before it is clinically significant, suggests that the loss of AP-2α may potentially influence cancer progression by deregulating MMP-2 gene. Here, MMP2 is linked to cancer.